Skip to main content
. Author manuscript; available in PMC: 2021 Aug 3.
Published in final edited form as: J Mol Cell Cardiol. 2021 Feb 6;154:97–105. doi: 10.1016/j.yjmcc.2021.01.011

Fig. 1. Integrating epigenomics into patient care.

Fig. 1.

Epigenetic marks incorporate environmental and genetic factors into the pathophysiology of many aspects of cardiovascular disease. These epigenetic biosignatures can be used by clinicians to treat disease and monitor individual response to treatment. Integrating epigenetic data, analysis and clinician education into patient care are crucial next steps in implementation to improve clinical care at a population level.